We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PARIS and BOSTON, Jan. 21, 2016 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV) a leader in active immunotherapies for the treatment of autoimmune diseases, today signed a partnering...
ADVISORY, Nov. 04, 2015 (GLOBE NEWSWIRE) -- What: Stellar Biotechnologies, Inc. (Nasdaq:SBOT), which specializes in manufacturing Keyhole Limpet Hemocyanin (KLH) protein, an...
PORT HUENEME, CA--(Marketwired - July 10, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), a leader in sustainable manufacture of Keyhole...
PORT HUENEME, CA--(Marketwired - June 06, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the appointment of Gregory T. Baxter...
Stellar Biotechnologies Appoints Two Members to Scientific Advisory Board PORT HUENEME, CA--(Marketwired - Jun 6, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB:...
PORT HUENEME, CA--(Marketwired - May 20, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the launch of its corporate video...
Stellar Biotechnologies Releases Corporate Video PORT HUENEME, CA--(Marketwired - May 20, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX-VENTURE: KLH...
Stellar Biotechnologies to Present at Two Upcoming Conferences PORT HUENEME, CA--(Marketwired - May 15, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF...
Stellar Biotechnologies Retains Stonegate for Institutional Outreach PORT HUENEME, CA--(Marketwired - May 7, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF...
Stellar Biotechnologies Launches New Corporate Website The New Website Showcases Stellar's Core KLH Products, Breakthroughs in Aquaculture Science, and Strategic Expansion of its Immunotherapy...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions